Sogroya 5 mg/ 1.5 ml
Sogroya 5 mg/ 1.5 ml is a medicine authorised by Swissmedic under authorisation number 69063. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 April 2024 and the authorisation is limited until 25 April 2029. ATC code H01AC07 places the medicine in the group Pituitary and hypothalamic hormones and analogues.
| Authorisation number | 69063 |
|---|---|
| Name | Sogroya 5 mg/ 1.5 ml |
| Full name | Sogroya 5 mg/ 1.5 ml, Injektionslösung im Fertigpen |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | H01AC07 |
| First authorisation | 26 April 2024 |
| Authorisation validity | 25 April 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sogroya 5 mg/ 1.5 ml, Injektionslösung im Fertigpen | A | 26 April 2024 |
| 2 | Sogroya 10 mg/ 1.5 ml, Injektionslösung im Fertigpen | A | 26 April 2024 |
| 3 | Sogroya 15 mg/ 1.5 ml, Injektionslösung im Fertigpen | A | 26 April 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1.5 | ml | H01AC07 | 07.03.1. | A |
| 2 | 1.5 | ml | H01AC07 | 07.03.1. | A |
| 3 | 1.5 | ml | H01AC07 | 07.03.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Sogroya 5 mg/ 1.5 ml authorised in Switzerland?
Yes. Sogroya 5 mg/ 1.5 ml is authorised by Swissmedic under authorisation number 69063, data as of 01 September 2026. The authorisation is limited until 25 April 2029.
Which dispensing category does Sogroya 5 mg/ 1.5 ml have?
Sogroya 5 mg/ 1.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Sogroya 5 mg/ 1.5 ml?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.